Summa Health System - Barberton Campus — Barberton, Ohio

Summa Health System - Barberton Campus is a clinical research site located in Barberton, Ohio, United States 44203.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Summa Health System - Barberton Campus has participated in 50 clinical trials with 29 currently active.

Therapeutic areas: Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8.

Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), NRG Oncology.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Summa Health System - Barberton Campus?

Summa Health System - Barberton Campus has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Summa Health System - Barberton Campus conducted?

Summa Health System - Barberton Campus has 50 clinical trials on record, with 29 currently active. Their work covers Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8.

Is Summa Health System - Barberton Campus accredited by Crixeo Health?

Yes — Summa Health System - Barberton Campus holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Summa Health System - Barberton Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.